GenSight raises €30mn in an oversubscribed private placement in EU and US
PARIS: GenSight Biologics has announced that the company has successfully raised €30 million in an oversubscribed private placement with European and US institutional investors. The Company has issued 4.477 million new ordinary shares with a nominal value of €0.025 each,…